Talon Therapeutics, Inc. (TLON) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 12 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jul 17, 2013 involved a transaction of 184,192 shares valued at $0.
No significant insider buying has been recorded for TLON in the recent period.
No significant insider selling has been recorded for TLON in the recent period.
Based on recent SEC filings, insider sentiment for TLON is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at Talon Therapeutics, Inc. (TLON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading TLON stock, having executed 12 transactions in the past 90 days. The most active insider is Pincus &. Co. Warburg (Executive), who has made 4 transactions totaling $76.8M.
Get notified when executives and directors at TLON file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 17, 2013 | R. Deitcher Steven | Executive | Disposition | 184,192 | $N/A | $0 | |
| Jul 17, 2013 | Maier Paul V | Executive | Disposition | 1,750 | $N/A | $0 | |
| Jul 17, 2013 | E. Rosenberg Leon | Executive | Disposition | 250 | $N/A | $0 | |
| Jul 16, 2013 | &. Co. Warburg Pincus | Executive | Sale | 0 | $0.06 | $0 | |
| Jul 16, 2013 | &. Co. Warburg Pincus | Executive | Conversion | 49,537,551 | $0.35 | $17.3M | Large |
| Jul 16, 2013 | &. Co. Warburg Pincus | Executive | Conversion | 37,775,503 | $0.30 | $11.3M | Large |
| Jul 16, 2013 | &. Co. Warburg Pincus | Executive | Conversion | 65,016,890 | $0.74 | $48.1M | Large |
| Jul 16, 2013 | H. Weatherman Elizabeth | Executive | Conversion | 65,016,890 | $0.74 | $48.1M | Large |
| Jul 16, 2013 | H. Weatherman Elizabeth | Executive | Conversion | 37,775,503 | $0.30 | $11.3M | Large |
| Jul 16, 2013 | H. Weatherman Elizabeth | Executive | Sale | 0 | $0.06 | $0 | |
| Jul 16, 2013 | H. Weatherman Elizabeth | Executive | Conversion | 49,537,551 | $0.35 | $17.3M | Large |
| Feb 2, 2011 | R. Deitcher Steven | Executive | Award | 179,192 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 6 | $153.6M | 100.0% |
Disposition(D) | 3 | $0 | 0.0% |
Sale(S) | 2 | $0 | 0.0% |
Award(A) | 1 | $0 | 0.0% |
Insider activity at Talon Therapeutics, Inc. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.5 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Pincus &. Co. Warburg, has transacted $76.8M during this period.